TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
Qifang Zhang, Marcin Kortylewski(City Of Hope National Medical Center)
Cited by 109
Related Papers
Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity
|Journal of Clinical Investigation|2020|82
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
|Molecular Therapy — Nucleic Acids|2024|31